Schedule 13D ownership disclosure

INDAPTUS THERAPEUTICS INC

Common Stock, $0.01 par value · CUSIP: 45339J105

Event date: 2026-02-26

Filing-level shares
111,000,000.00
Percent of class
98%
  • Lazar David E.Reported CIK 0001932843

    Shares: 111,000,000.00 · Class: 98%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001829126-26-001810
Form type
SCHEDULE 13D
Filer
Indaptus Therapeutics, Inc.
CIK
CIK 1857044
Filed
Mar 02, 2026
Reporting period
Feb 26, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub